Answers are grounded in this paper and cite their sources.
Candida albicansis fungus capable of changing from yeast to filamentous form when it’s transformed from a normal commensal to an opportunistic pathogen. The development of alternatives that interfere with this transition could be an effective way to reduce candidiasis. In this regard, evaluate the inhibitory effect of twoBorojoa patinoisilver nanoparticles (AgNPs) produced by green synthesis at 5 °C and 25 °C on the process of filamentation ofCandida albicans. The percentage of inhibition of filamentous forms ofC. albicansATCC10231 andC. albicansSC5314 with AgNPs was determined. Results showed that temperature of synthesis affected both the shape and size of silver nanoparticles synthesized usingBorojoa patinoiextracts. The inhibition percentage of filamentous forms ofCandida albicansATCC10231 when treated with silver nanoparticles synthesized at 5 °C was 85.9% and at 25 °C it was 40%.C. albicansSC5314 when treated with AgNP synthesized at 5 °C was 97.2% and at 25 °C it was 64%. Cell toxicity assay showed that at 100ng/ml, AgNPs synthesized at 25 °C were safe in MES-OV CRL-3272 cell line. Our results showed that the silver nanoparticles obtained fromBorojoa patinoiare inhibitors of the filamentous process ofC. albicans.
No takes yet. Share an insight, caveat, or question.
Garzón et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: